Management of urethral recurrence after orthotopic urinary diversion.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 20002676.
- Also identified by DOI 10.1111/j.1464-410X.2009.09095.x.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Therapy (case series) Level of Evidence 4 OBJECTIVE To evaluate our experience with urethral recurrences in patients treated by radical cystectomy(RC) and orthotopic neobladder urinary diversion for carcinoma of the bladder. We retrospectively reviewed the records of patients treated with RC and orthotopic urinary diversion between January 1980 and July 2004. In all, 260 patients underwent RC with a Studer or Hautmann orthotopic urinary diversion; the median (range) follow-up was 5.1 (0-15.6) years. Six patients (2.3%) developed local recurrence of urothelial cancer (UC) within the urethra after this treatment. The median (range) time to presentation with recurrence after RC was 2.4 (0.7-3.6) years for pT1-4 UC. Recurrences were treated with various methods, including transurethral resection, urethrectomy with conversion of neobladder to continent catheterizable diversion, and chemotherapy. At the last follow-up, four of these six patients were alive without disease, one was alive with disease, and one had died from disease. In our experience, local recurrences involving the urethra are infrequent. Complete surgical excision can provide a good outcome. Neoadjuvant chemotherapy should be considered for recurrences with adverse clinicopathological features.
Medical subject headings
- Carcinoma, Transitional Cell
- Cystectomy
- Neoplasm Recurrence, Local
- Urethral Neoplasms
- Urinary Bladder Neoplasms
- Urinary Diversion